Last reviewed · How we verify

NCT05408013

The Prevalence of Insomnia in Patients With Psychiatric Disorders

Completed Last updated 3 April 2026
What this trial tests

trial in Insomnia in 427 participants. Completed in 31 March 2025.

Timeline
1 July 2021
Primary endpoint
31 March 2025
31 March 2025

Quick facts

Lead sponsorUniversity of Bern
StatusCompleted
Study typeOBSERVATIONAL
Enrollment427
Start date1 July 2021
Primary completion31 March 2025
Estimated completion31 March 2025
Sites1 location across Switzerland

Conditions studied

Sponsor

University of Bern

Who can join

18 and older, any sex, with Insomnia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary aim of the proposed project is to investigate the prevalence of insomnia in patients with psychiatric disorders treated as inpatients in psychiatric hospitals in two study sites in Switzerland and nine study sites in Germany. The secondary aim is to investigate whether there are demographic or disorder specific parameters that influence the prevalence of insomnia in patients with psychiatric disorders.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Insomnia

Currently open trials in the same condition.

Other University of Bern trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05408013.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing